Silk fibroin sponges loaded with LL-37-derived antimicrobial peptides FK-16 and GF-17 provide sustained local delivery to combat Staphylococcus implant infections in orthopedics.
Dual function: antimicrobial + osteoinductiveSilk sponges can deliver infection-fighting peptides while also containing bone-stimulating peptides to promote healing
What the researchers found
Silk fibroin sponges successfully loaded with FK-16 and GF-17 antimicrobial peptides showed sustained release properties suitable for local control of orthopedic implant infections.
Why it matters
Implant infections often require implant removal and prolonged antibiotic treatment. A local antimicrobial sponge could prevent infections at the surgical site while promoting bone healing.
The numbers in context
FK-16: >90% release within 24 h, then stable plateau. Bactericidal against MRSE clinical strains. GF-17: lower release efficiency, weaker antimicrobial effect. Neither effective against MRSA in this system.
How the study worked
Materials science study developing and characterizing silk fibroin (SF) and osteoinductive peptide-enriched SF (PSF) sponges for local FK-16 and GF-17 delivery, assessing swelling, release kinetics, and antimicrobial properties.
Who was studied
MRSE and MRSA clinical strains (in vitro)
What this study cannot tell us
In vitro study — release kinetics and antimicrobial efficacy in surgical settings remain to be tested. Biocompatibility in living tissue needs validation.
How to read the evidence
In vitro materials characterization study. While the sponge design is promising, clinical efficacy in preventing actual implant infections remains to be demonstrated.
When this study was published
Published in 2025, contributing to the active field of antimicrobial biomaterial development for orthopedics.
The bigger picture
Combining antimicrobial peptides with biocompatible delivery materials represents a growing strategy for infection prevention in implant surgery, potentially reducing antibiotic use and reoperation rates.
Questions still open
- How long does antimicrobial protection last from the silk sponges in vivo?
- Can the sponges prevent biofilm formation on implant surfaces?
Common questions
Why are implant infections so serious in orthopedics?
What are FK-16 and GF-17?
Read the original research
Development of Silk Fibroin-Based Sponges Loaded with LL-37-Derived Peptides for the Control of Orthopedic Infections.
International journal of molecular sciences, 26(16)
Citation
Pennone, Vincenzo; Meogrossi, Giada; Carenzi, Giacomo; Sarlah, David; Biagiotti, Marco; Lovati, Arianna B. (2025). Development of Silk Fibroin-Based Sponges Loaded with LL-37-Derived Peptides for the Control of Orthopedic Infections.. International journal of molecular sciences, 26(16). https://doi.org/10.3390/ijms26167775